Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Pancreatic carcinoma metastatic
ADR ID BADD_A07531
ADR Hierarchy
07      Gastrointestinal disorders
07.21      Malignant and unspecified neoplasms gastrointestinal NEC
07.21.09      Pancreatic neoplasms
07.21.09.006      Pancreatic carcinoma metastatic
16      Neoplasms benign, malignant and unspecified (incl cysts and polyps)
16.13      Gastrointestinal neoplasms malignant and unspecified
16.13.10      Pancreatic neoplasms malignant (excl islet cell and carcinoid)
16.13.10.003      Pancreatic carcinoma metastatic
Description Not Available
MedDRA Code 10033610
MeSH ID Not Available
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Cancer of head of pancreas metastatic | Cancer of pancreas (excl head) metastatic | Malignant neoplasm of body of pancreas metastatic | Malignant neoplasm of head of pancreas metastatic | Malignant neoplasm of pancreas metastatic | Malignant neoplasm of tail of pancreas metastatic | Pancreas neoplasm malignant metastatic | Pancreatic adenocarcinoma metastatic | Pancreatic cancer metastatic | Pancreatic carcinoma metastatic
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D00066Alendronic acid0.000044%
BADD_D00151Apixaban0.000195%
BADD_D00194Azacitidine0.000112%
BADD_D00349Capecitabine0.000224%
BADD_D00364Carboplatin0.000168%
BADD_D00474Cisplatin0.000112%
BADD_D00680Dimethyl fumarate0.000600%
BADD_D00800Erlotinib0.000728%
BADD_D00879Fentanyl0.000634%
BADD_D01009Gemcitabine--
BADD_D01195Irinotecan0.000112%
BADD_D01633Oxaliplatin0.000112%
BADD_D01653Paclitaxel0.004723%
BADD_D02029Sitagliptin0.002070%
BADD_D02100Sunitinib0.000112%
BADD_D02331Valsartan0.000053%
BADD_D02407Upadacitinib0.000241%
BADD_D02526Larotrectinib0.000168%
The 1th Page    1    Total 1 Pages